A comprehensive study published in The Lancet Digital Health analyzed the efficacy and challenges of AI in clinical settings, ...

Black Americans can respond differently to medical treatments. Learn why genetics and environment cause racial drug ...

Drew Bouton, from Olympia, Wash., is one of those patients. Drew lives with metastatic prostate cancer and receives treatment ...

In a landmark study, an international consortium led by researchers at Children's Hospital of Philadelphia (CHOP) published ...

A digital clinical trial company in Chelsea is laying off half its U.S. workforce this summer to move production overseas, ...

A cancer drug was found to be ineffective in preventing recurrence of kidney cancer in patients who recently underwent tumor ...

A Swiss startup called Risklick has launched artificial intelligence software for clinical trials that the company claims can ...

The prevalence of low amyloid levels in Black people opens up a host of questions regarding the development of Alzheimer’s ...

By definition, rare diseases affect only a small number of patients. However, recruiting cohorts of sufficient size is not ...

At CTS New England 2024, clinical trial supply managers were called to leverage technology to reduce the risk of drug ...

Blockchain and AI technologies pioneer a new method for connecting patients directly with clinical trial research, enhancing privacy, efficiency, and engagement. In a groundbreaking advancement for ...

Parexel has struck a multi-year deal with Palantir Technologies to integrate its artificial intelligence systems into Parexel ...